Amsterdam, 11 November 2024 EXOR N.V.: PERIODIC REPORT ON THE BUYBACK PROGRAM Exor N.V. (AMS: EXO) (“Exor” or the “Company”) announces that, under the second tranche of the share buyback program of up to €125 million announced on 12 August 2024 (the “Second Tranche”), the Company has completed the following transactions on Euronext Amsterdam, CBOE DXE, Turquoise Europe and Aquis Exchange Europe: EURONEXT AMSTERDAM Trading Date Number of ordinary shares purchased Average price per share excluding fees (€) Total consideration excluding fees (€) 4 November 2024 2,133 97.31 207,559.03 5 November 2024 32,364 95.12 3,078,418.37 6 November 2024 15,188 94.64 1,437,431.81 TOTAL 49,685 4,723,409.21 CBOE DXE Trading Date Number of ordinary shares purchased Average price per share excluding fees (€) Total consideration excluding fees (€) 4 November 2024 592 96.70 57,246.40 5 November 2024 8,247 93.84 773,867.97 6 November 2024 2,895 94.70 274,148.10 TOTAL 11,734 1,105,262.47 TURQUOISE EUROPE Trading Date Number of ordinary shares purchased Average price per share excluding fees (€) Total consideration excluding fees (€) 5 November 2024 524 94.95 49,754.27 6 November 2024 653 94.24 61,537.09 TOTAL 1,177 111,291.36 AQUIS EXCHANGE EUROPE Trading Date Number of ordinary shares purchased Average price per share excluding fees (€) Total consideration excluding fees (€) 5 November 2024 1,350 95.57 129,024.50 6 November 2024 928 94.80 87,969.95 TOTAL 2,278 216,994.44 After these purchases, the total invested amount under the second tranche is approximately €125 million for a total amount of 1,287,107 ordinary shares purchased. With the purchases described above the Company has completed the second tranche of the share buyback program announced on 12 August 2024 which was a restart of the buyback program announced on 13 September 2023. As of 11 November 2024, the Company held in total 7,250,871 ordinary shares in treasury (3.28% of total ordinary issued share capital)1. A comprehensive overview of the transactions carried out under the share buyback program, as well as the details of the above transactions, are available on Exor’s corporate website under the Share Buyback section. 1 This corresponds to 1.00% of the total issued share capital including both ordinary shares and special voting shares. Attachment Exor Press Release - W45-24 Buyback View Comments
Exor Press Release - Periodic Report on the Buyback Program
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...